The Outcome of the Parasitic Process Initiated by Leishmania infantum in Laboratory Mice: A Tissue-Dependent Pattern Controlled by the Lsh and MHC Loci

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4537-4545

  Leclercq, Véronique ^a   Lebastard, Maï ^a   Belkaid, Yasmine ^a   Louis, Jacques ^b   Milon, Geneviève ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CATION TRANSPORT PROTEIN; IRON BINDING PROTEIN; MEMBRANE PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1; SOLUTE CARRIER FAMILY 11 (PROTON COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 2; SOLUTE CARRIER FAMILY 11- (PROTON-COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 2;

ALLELE; ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; FEMALE; GENETICS; IMMUNOLOGY; LEISHMANIA INFANTUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; PARASITIC LIVER DISEASE; PARASITOLOGY; SPLEEN DISEASE; VISCERAL LEISHMANIASIS;

ALLELES; ANIMALS; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; FEMALE; IRON-BINDING PROTEINS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LIVER DISEASES, PARASITIC; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; ORGAN SPECIFICITY; SPLENIC DISEASES;

EID: 0030588671     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Ross, R. 1903. Further notes on the Leishman's bodies. Br. Med. J. 2219:1401.
2. World Health Organization. 1993. The leishmaniases. In Control of Tropical Diseases. World Health Organization, Geneva.
3. Gradoni, L., and M. Gramiccia. 1994. Leishmania infantum tropism: strain genotype or host immune status? Parasitol. Today 10:264.
4. Warburg, A. E., G. C. Saraiva, C. Lanzaro, R. G. Titus, and F. Neva. 1994. Saliva of Lutzomia longipalpes sibling species differs in its composition and capacity to enhance leishmaniasis. Philos. Trans. R. Soc. Lond-Biol. Sci. 345: 223.
5. Pampiglione, S., P. E. C. Manson-Bahr, F. Giungi, G. Giunti, A. Parenti, and G. Canestri Trotti. 1974. Studies on Mediterranean leishmaniasis: asymptomatic cases of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 68:447.
6. Badaro, R., T. C. Jones, E. M. Carvalho, D. Sampaio, S. G. Reed, A. Barral, R. Texeira, and W. D. Johnson. 1986. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 154:1003.
7. Wilson, M. E. V. 1995. Leishmaniasis. Curr. Opin. Infect. Dis. 6:331.
8. Pearson, R. D., and A. de Queiroz Souza. 1996. Clinical spectrum of leishmaniasis. Clin. Infect. Dis. 22:1.
9. De La Loma, A., J. Alvar, E. Martinez Galiano, J. Blazquez, A. Alcala Munoz, and A. Najera. 1985. Leishmaniasis or AIDS? Trans. R. Soc. Trop. Med. Hyg. 79:421.
10. Clauvel, J. P., L. J. Couderc, J. Belmin, M. T. Daniel, C. Rabian, and H. Seligmann. 1986. Visceral leishmaniasis complicating acquired immunodeficiency syndrome. Trans. R. Soc. Trop. Med. Hyg. 80:1010.
11. Senaldi, G., G. Cadeo, G. Carnavale, D. G. Perri, and G. Carosi. 1986. Visceral leishmaniasis as an opportunistic infection. Lancet 1:1094.
12. Rosenthal, E., P. Marty, I. Poizot-Martin, J. Reynes, F. Pratlong, A. Lafeuillade, D. Jaubert, O. Boulat, J. Dereure, F. Gambailli, J. A. Gastant, P. Dujardin, P. Dellamonica, and J. P. Cassuto. 1995. Visceral leishmaniasis and HIV-1 co-infection in Southern France. Trans. R. Soc. Trop. Med. Hyg. 89:159.
13. Altes, J., A. Salas, M. Riera, M. Udina, A. Galmes, J. Balanzat, A. Ballesteros, J. Buades, F. Salva, and C. Villalonga. 1991. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS 5:201.
14. Medrano, F. J., J. Hernandez-Quero, E. Jimenez, J. A. Pineda, A. Rivero, A. Sanchez- Quijano, I. D. Velez, P. Viciana, R. Castillo, M. J. Reyes, F. Carvajal, M. Leal, and E. Lissen. 1992. Visceral leishmaniasis in HIV-1 infected individuals: a common opportunistic infection in Spain? AIDS 6:1499.
15. Alvar, J., J. Blasquez, and R. Najera. 1989. Association of visceral leishmaniasis and human immunodeficiency virus infections. J. Infect. Dis. 160:560.
16. Gramiccia, L., M. Gradoni, and M. Troiani. 1992. HIV-Leishmania co-infection in Italy: isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients. Trans. R. Soc. Trop. Med. Hyg. 86:161.
17. Alvar, J. 1994. Leishmaniasis and AIDS co-infection: the Spanish example. Parasitol. Today 10:160.
18. Paigen, K. 1995. A miracle enough: the power of mice. Nat. Med. 1:215.
19. McLeod, R., E. Bushman, L. D. Arbuckle, and E. Skamene. 1995. Immunogenetics in analysis of resistance to intracellular pathogens. Curr. Opin. Immunol. 7:559.
20. Bradley, D. J. 1974. Genetic control of natural resistance to Leishmania donovani. Nature 250:353.
21. Bradley, D. J. 1977. Regulation of Leishmania populations within the host. II. Genetic control of acute susceptibility of mice to Leishmania donovani infection. Clin. Exp. Immunol. 30:130.
22. Bradley, D. J., B. A. Taylor, J. Blackwell, E. P. Evans, and J. Freeman. 1979. Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin. Exp. Immunol. 37:7.
23. Blackwell, J. M. 1996. Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious autoimmune disease susceptibility. Mol. Med. Today 1:205.
24. Cellier, M., A. Belouchi, and P. Gros. 1996. Resistance to intracellular infections: comparative genomic analysis of Nramp1. Trends Genet. 12:201.
25. Crocker, P. R., J. M. Blackwell, and D. J. Bradley. 1984. Expression of the natural resistance gene Lsh in resident liver macrophages. Infect. Immun. 43: 1033.
26. Blackwell, J., J. Freeman, and D. Bradley. 1980. Influence of H2 complex on acquired resistance to Leishmania donovani infection in mice. Nature 283:72.
27. Blackwell, J. M. 1982. Genetic control of recovery from visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 76:147.
28. Blackwell, J. M., C. Hale, M. B. Roberts, O. M. Ulczack, F. Y. Liew, and J. G. Howard. 1985. An H-11 linked gene has a parallel effect on Leishmania major and Leishmania donovani infections in mice. Immunogenetics 21:385.
29. Roberts, M., P. M. Kaye, G. Milon, and J. M. Blackwell. 1989. Studies of immune mechanisms in H-11-linked genetic susceptibility to murine visceral leishmaniasis. In Leishmaniasis-The Current Status and New Strategies for Control. D. T. Hart, ed. Plenum Press, New York, p. 29.
30. Crocker, P. R., S. Kelm, L. Morris, D. F. Bainton, and S. Gordon. 1992. Cellular interactions between stromal macrophages and haematopoietic cells. In Mononuclear Phagocytes: Biology of Monocytes and Macrophages. Ch. 7. R. van Furth, ed., Kluwer Academic Publishers, Dordrecht, p. 55.
31. Kraal, G. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132:31.
32. Gordon, S., S. Clark, D. Greaves, and A. Doyle. 1995. Molecular immunobiology of macrophages: recent progress. Curr. Opin. Immunol. 7:24.
33. r) controlling resistance to intracellular parasites. Infect. Immun. 40: 1234.
34. Berens, R. L., and J. J. Marr. 1978. An easily prepared defined medium for cultivation of Leishmania donovani promastigotes. J. Parasitol. 64:160.
35. Titus, R. G., M. Marchand, T. Boon, and J. A. Louis. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545.
36. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. 1. Data analysis. J. Immunol. 126:1614.
37. Strijbosch, L. W. G., W. A. Buurman, R. J. M. M. Does, P. H. Zinken, and G. Groenewegen. 1987. Limiting dilution assays: experimental design and statistical analysis. J. Immunol. Methods 97:133.
38. Buffet, P. A., A. Sulahian, J. F. Garin, N. Nassar, and F. Derouin. 1995. Culture micro-titration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob. Agents Chem. 39:2167.
39. Stauber, L. A. 1958. Host resistance to the Khartoum strain of Leishmania donovani. Rice Inst. Pamph. 45:80.
40. Crocker, P. R., and S. Gordon. 1989. Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterised by a monoclonal antibody. J. Exp. Med. 169:1333.
41. Rabinowitz, S. S., and S. Gordon. 1991. Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli (published erratum appears in J. Exp. Med. 1992, 175:309). J. Exp. Med. 174:827.
42. da Silva, R. P., N. Platt, W. J. S. de Villiers, and S. Gordon. 1996. Membrane molecules and macrophage endocytosis: scavenger receptor and macrosialin as markers of plasma membrane and vacuolar functions. Biochem. Soc. Trans. 24: 220.
43. Blackwell, J. 1983. Leishmania donovani infection in heterozygous and recombinant H2 haplotype mice. Immunogenetics 18:101.
44. Leclerc, C., F. Moddaber, E. Deriaud, and L. Chedid. 1981. Systemic infection of Leishmania tropica (major) in various strains of mice. Trans. R. Soc. Trop. Med. Hyg. 75:851.
45. Aebischer, T., S. F. Moody, and E. Handman. 1993. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 61:220.
46. Aebischer, T. 1994. Recurrent cutaneous leishmaniasis: a role for persistent parasites? Parasitol. Today 10:25.
47. Stenger, S., N. Donhauser, H. Thüring, M. Röllinghoff, and C. Bogdan. 1996. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183:1501.
48. Davies, E. V., A. M. T. Singleton, and J. M. Blackwell. 1988. Differences in Lsh gene control over systemic Leishmania major and Leishmania donovani or Leishmania mexicana mexicana infections are caused by differential targeting to infiltrating and resident liver macrophages population. Infect. Immun. 56:1128.
49. Stein, M., and S. Keshav. 1992. The versatility of macrophages: a review. Clin. Exp. Allergy 22:19.
50. Crocker, P. R., E. V. Davies, and J. M. Blackwell. 1987. Variable expression of the murine natural resistance gene Lsh in different macrophage populations infected in vitro with Leishmania donovani. Parasite Immunol. 9:705.
51. Oliver, M., and C. E. Tanner. 1987. Susceptibilities of macrophage populations to infection in vitro by Leishmania donovani. Infect. Immun. 55:467.
52. Vidal, S., M. L. Tremblay, G. Goroni, S. Gauthier, G. Sebastiani, D. Malo, E. Skamene, M. Oliver, S. Jothy, and P. Gros. 1995. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182:655.
53. Nathan, C. 1995. Natural resistance and nitric oxide. Cell 82:873.
54. Blackwell, J. M., C. H. Barton, J. K. White, T. I. A. Roach, M. A. Shaw, S. H. Whitehead, B. A. Mock, S. Searle, H. Williams, and A. M. Baker. 1994. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunol. Lett. 43:99.
55. Barton, C., S. H. Whitehead, and J. M. Blackwell. 1995. Nramp transfection transfers Ity/Lsh/Bcg pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways. Mol. Med. 1:267.
56. Gordon, S., L. Lawson, S. Rabinowitz, P. R. Crocker, L. Morris, and V. H. Perry. 1992. Antigen markers of macrophage differentiation in murine tissues. Curr. Top. Microbiol. Immunol. 181:1.
57. Dijkstra, C. D., and G. Kraal. 1991. Nonlymphoid cells in the splenic white pulp. Res. Immunol. 142:325.
58. Formica, S., T. I. A. Roach, and J. M. Blackwell. 1994. Interaction with extracellular matrix proteins influences Lsh/Ity/Bcg (candidate Nramp) gene regulation of macrophage priming/activation for tumor necrosis factor-α and nitrite release. Immunology 82:42.
59. Blackwell, J. M. 1996. Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 112:567.